How US doctors collaborated in response to COVID-19’s alarming propensity for clots
The phenomenon has fueled a drive to develop new treatment protocols
As SARS-CoV-2 spread through New York City in late March, doctors at Mount Sinai Hospital noticed something strange happening to patients’ blood.
Signs of blood clotting were being detected in different organs by doctors from different specialties. This would turn out to be one of the alarming ways the virus ravages the body, as doctors there and elsewhere were starting to realise.
